Professor Burgess
- Home
- Curriculum Vitae
- Publications
- Research Summary
- Contributor to "Highlights" in Chemistry and Industry Journal
- Speaking Engagements
- Center for the Development of High Resolution Probes for Cellular Imaging
- Office Staff
- Openings for Postdoctoral Fellows
The Burgess Group
Solid Phase Synthesis of Peptidomimetics

Figure 1. Nerve growth factor (NGF) dimer with the beta-turn regions highlighted
Solid phase SnAr macrocyclizations and related reactions have enabled us to prepare
beta-turn mimics in a library format. Beta-Turns are pivotal to many protein-protein interactions.
We are attempting to prepare and test small molecule mimics of nerve growth factor (NGF).
Functional mimics of this proteins could be useful in treatment of neurodegenerative
diseases including Alzheimer's disease, ALS Lou Gehring's disease, trauma, and of
various forms of cancer. The approach that we are using for to mimic neurotrophis
could also be applied to other proteins that dock with transmembrane receptors.
Figure 2 shows the key macrocyclization step in a synthesis of one peptidomimetic,
and the results of a confomational analysis of one such compound performed
using NMR and computer simulations.


c
Figure 2. a. Key macrocyclization step in a peptidomimetic synthesis. b. Preferred conformation of one such peptidomimetic from NMR and computational studies. c. Our dimerization scheme for forming homo- and hetero-bivalent dimers.
Molecules in which two turn mimics are joined together have the potential for much higher affinity
binding to other proteins than ones that only resemple one hot-spot. Recently we devised a method for
joining monovalent molecules together to form bivalent ones. This method tolerates unprotected side
chains and does not require coupling agents. Yiends in relatively large libraries of bivalent molecules.
Our research initiative is focused on overcoming the logistical problems of doing this.
a

b

Figure3. a. Libraries of bivalent compounds made by combining all available monovalent comounds in all permutations rapidly build up numbers, but tending to waste valuable building blocks exploring unproductive areas of diversity space; whereas, b. an evolving strategy that perseveres only with the monovalent compounds that have shown activity and focuses the libary as it evolves.
Ultimately, we hope to be able to test the concept of "evolving libraries" as outlined in
Figure 3. This avoids the problems of manipulating large numbers of molecules that
would be encountered if a complete library were made and tested (Figure 3a), while
providing a comparable diversity.